US$ 26.37
glp 1 drugs for weight loss cost Study finds 40% of GLP-1 prescriptions go unfilled: Is curbing use of drugs? GLP-1 Agonists Weight Loss Drugs
Description
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

Glucagon-like peptide-1 (GLP-1) is a natural hormone released in the intestines to regulate blood sugar levels and metabolism

Discover how GLP-1 receptor agonists like semaglutide may reduce inflammation beyond blood sugar control

Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

22, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

Allulose in human diet: the knowns and the unknowns - Volume 128 Issue 2